[ 1 ] McAlister F A, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades [J]. Canadian Medical Association Journal，2011,183(9): 1007–1013.
McAlister FA, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ, 2011, 183(9):1007–1013. 链接1

[ 2 ] Robitaille C, Dai S, Waters C, et al. Diagnosed hypertension in Canada: Incidence, prevalence and associated mortality [J]. Cana-dian Medical Association Journal，2012, 184(1): 49–56.
Robitaille C,Dai S,Waters C, et al. Diagnosed hypertension in Can-ada: incidence, prevalence and associated mortality. CMAJ,2012, 184(1):49–56. 链接1

[ 3 ] Schiffrin E L, Campbell N R, Feldman R D, et al. Hypertension in Canada: Past, present, and future [J]. Annals of Global Health, 2016, 82(2): 288–299.
Schiffrin EL, Campbell NR, Feldman RD, et al. Hypertension in Canada: Past, Present, and Future. Annals of Global Health, 2016,82(2):288–299. 链接1

[ 4 ] Chockalingam A, Campbell N, Ruddy T, et al. Canadian national high blood pressure prevention and control strategy [J].Canadian Journal of Cardiology, 2000 , 16(9): 1087–1093.
Chockalingam A,Campbell N,Ruddy T,et al. Canadiannationalhigh blood pressureprevention and controlstrategy.Can J Cardiol,2000, 16(9):1087–1093. 链接1

[ 5 ] Chockalingam A, Abbott D, Bass M, et al. Recommendations of the Canadian consensus conference on nonpharmacological approaches to the management of high blood pressure [J]. Cannadian Medical Association Journal, 1990,142(12): 1397–1409.
Chockalingam A, Abbott D, Bass M, et al. Recommendations of the Canadian consensus conference on nonpharmacological approaches to the management of high blood pressure. Can Med Assoc J, 1990, 142(12): 1397–1409. 链接1

[ 6 ] Campbell N R, Brant R, Johansen H, et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada [J]. Hypertension, 2009, 53(2): 128–134.
Campbell NRC, Brant R, Johansen H, et al. Increases in antihy-pertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension, 2009, 53(2): 128–134. 链接1

[ 7 ] Mcalister F A, Feldman R D, Wyard K, et al. The impact of the Canadian Hypertension Education Programme in its first decade[J]. European Heart Journal, 2009, 30(12): 1434–1439.
McAlister FA, Feldman RD, Wyard K, et al. The impact of the Ca-nadian Hypertension Education Programme in its first decade. Eur Heart J, 2009, 30(12):1434–1439. 链接1

[ 8 ] Campbell N R, Petrella R, Kaczorowski J. Public education on hypertension: A new initative to improve the prevention, treatment and control of hypertension in Canada[J]. Canadian Journal of Cardiology, 2006, 22(7): 599–603.
Campbell NR, Petrella R, Kaczorowski J. Public education on hypertension: a new initative to improve the prevention, treat-ment and control of hypertension in Canada. Can J Cardiol, 2006, 22(7):599–603. 链接1

[ 9 ] Sodium Working Group. Sodium reduction strategy for Canada: 121中国工程科学 2017 年 第 19 卷 第 2 期Recommendations of the sodium working group [R].
Sodium Working Group. Sodium reduction strategy for Canada: Recommendations of the sodium working group[R].

[10] Kaczorowski J Chambers L W, Dolovich L, et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP) [J]. British Medical Journal , 2011(342): d442.
Kaczorowski J,Chambers LW,Dolovich L, et al. Improving car-diovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ, 2011(342):d442. 链接1

[11] Gutkin C. The future of family practice in Canada: The patient’s medical home [J]. Canadian Family Physician, 2011 , 57(10): 1224.
Gutkin C. The future of family practice in Canada: the patient’s medical home. Canadian Family Physician, 2011, 57(10):1224. 链接1